中信海直(000099.SZ):已與多家國內外企業共同開展eVTOL的合作,不斷探索城市空中交通運行模式
格隆匯7月31日丨有投資者向中信海直(000099.SZ)提問,“eV-T-OL是未來一個大賽道,深圳-珠海往返eV-T-OL航線有望開通,作為深圳企業,公司是否有eV-T-OL相關業務或者技術儲備?是否和eV-T-OL相關企業進行合作?”
中信海直回覆稱,中信海直作為國內領先的通航企業,密切關注通航產業的技術發展,根據不同的適應場景,選擇最為合適的航空器,實現融合發展、協同合作,目前公司已經與多家國內外企業共同開展eVTOL的合作,不斷探索城市空中交通運行模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.